Arlington Skin Cancer Detection
Discover Advanced Skin Cancer Detection
At SkinDC, our board-certified dermatologists and expert providers offer Dermtech, an innovative and non-invasive skin cancer detection technology.
With Dermtech, we can accurately identify suspicious moles and lesions at an early stage, providing our patients with peace of mind and proactive care. Experience the future of skin cancer screening at SkinDC with our experienced team of dermatology specialists.
What Is Dermtech?
A non-invasive patch biopsy involving the removal of epithelial cells using an adhesive patch. The skin cells are then processed and examined under a PCR machine or in some other fashion to obtain diagnostic information.
DermTech’s proprietary process painlessly extracts RNA and DNA from skin tissue samples to find genomic markers of melanoma specifically and accurately.
Benefits of Dermtech at SkinDC
Dermtech revolutionizes skin cancer detection with its advanced technology, providing several key benefits to our patients at SkinDC.
By offering a non-invasive and highly accurate method of identifying suspicious moles and lesions, Dermtech ensures early detection and prompt treatment, ultimately enhancing patient outcomes.
With our board-certified dermatologists leading the way, SkinDC is committed to providing state-of-the-art skin cancer screening that prioritizes patient safety and well-being.
How Dermtech Works at SkinDC
Cancer starts when genes mutate within a cell. This altered cell duplicates and duplicates until enough cells exist to be seen under a microscope (and then, eventually, even without one).
At SkinDC, we utilize DermTech's groundbreaking technology to detect skin cancer at its earliest stages.
Unlike traditional methods that rely on visual examination, DermTech's genomic analysis can identify mutated cancerous cells long before they become visible to the naked eye or even under a microscope.
The Power of Genomic Analysis
DermTech's proprietary gene expression test targets specific genes associated with melanoma, such as PRAME and LINC00518. Using a process called RT-PCR (reverse transcription-polymerase chain reaction), billions of copies of these genes are amplified for detailed analysis by our expert scientists.
Understanding the Results
When DermTech's analysis reveals elevated levels of the PRAME and/or LINC00518 gene, it indicates the presence of melanoma.
This early detection allows our board-certified dermatologists to initiate prompt treatment, leading to better patient outcomes and enhanced peace of mind.